Meditech Access
Market access and reimbursement consulting for medical device and healthcare technology companies in France and Europe
Highlights
- New on EvolcAdded 2026-11-02
About Meditech Access
MediTech Access advises on market access and reimbursement strategies for medical devices and healthcare technologies. Services include strategy, public affairs, pricing and negotiations, medical writing, training, due diligence, business development and health economics.
It supports medical device and healthcare technology companies across the product life cycle, including in diagnostics, e-health and pharmaceuticals. The firm works in France and other European markets through a network of partners.
Founded in 2012, MediTech Access is headquartered in Versailles, France. Its team provides consulting and related professional services.
Product: Market access, reimbursement and health economics consulting for medical devices and healthcare technologies.
Jobs at Meditech Access
Leadership
- Michel Verhasselt · Founder & President/CEOSource: company website
More consulting & professional services companies
Melin Expertise
Chartered accounting and statutory audit firm in Poitiers, France, serving clients with accounting managementNew on EvolcMentory
Technical consulting, project delivery and recruitment for telecom, rail and energy infrastructure clientsNew on EvolcMeotec
Operational consulting and project-management support for organizations across sectorsNew on EvolcMercurial
Purchasing group and procurement advisory services for industrial businesses across several sectors in FranceNew on EvolcMergercircle
Off-market acquisition sourcing for private equity investors and strategic buyersYoung companyNew on EvolcMessine Expertise
Accounting, payroll, legal and business advisory services for companies in FranceYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
No confirmed website technologies in the latest recorded checks.
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.